Cargando…
Severe Multiple Sclerosis Manifesting upon GnRH Agonist Therapy for Uterine Fibroids
This case concerned a 39-year-old woman diagnosed with uterine fibroids. Upon initiation of gonadotropin-releasing hormone (GnRH) agonist therapy, she experienced various neurological deficits but did not seek medical attention because of gradual spontaneous symptom improvement. Upon completing four...
Autores principales: | Sakurai, Kenzo, Shinohara, Kensuke, Imai, Takeshi, Yamano, Yoshihisa, Hasegawa, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759690/ https://www.ncbi.nlm.nih.gov/pubmed/32759585 http://dx.doi.org/10.2169/internalmedicine.4839-20 |
Ejemplares similares
-
GnRH analogs for the treatment of heavy menstrual bleeding associated with uterine fibroids
por: Madueke-Laveaux, Obianuju Sandra, et al.
Publicado: (2022) -
Use of oral GnRH antagonists combined therapy in the management of symptomatic uterine fibroids
por: Di Spiezio Sardo, A, et al.
Publicado: (2023) -
Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015) -
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012) -
Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014)